Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Thoracic 1

Conditions

Glioblastoma 2Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Adenocarcinoma 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × elemene × Clear all
NCT04401059 2023-12-27

SELECT-2

Hangzhou Normal University

Phase 4 Unknown
744 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT05842746 2023-05-06

Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma

Peking Union Medical College Hospital

Phase 2 Not yet recruiting
74 enrolled
CNS

Glioblastoma

NCT04674527 2020-12-19

Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Unknown
30 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡